Understanding the origins of Malformations of the Cortical development
Ossola and Kalebic. Frontiers in Neuroscience 2022
The cerebral cortex – the outer brain layer – accounts approximately for half of the human and mammalian brain mass and controls language, memory, reasoning, and consciousness. Specialised cortex cells – the neural progenitors – are responsible for the specification, positioning and maturation of neurons in the cortex, which are essential for brain development. Alteration of any of these events leads to structural abnormalities of the cerebral cortex, called Malformations of Cortical Development (MCDs). By impairing brain development, MCDs result in abnormal brain size and thickness, which represent the basis of several neurodevelopmental disorders.
Nereo Kalebic and Chiara Ossola at the HT Neurogenomics Research Centre review how two key features of the neuronal progenitor cells, i.e. their ability to proliferate and polarise, impact on brain development, if misregulated. Furthermore, they discuss the role of cell signaling pathways and metabolism in the onset of MCDs and how using appropriate in vivo and in vitro models can help advancing personalized medicine. In summary, the authors provide a comprehensive overview of how the cell biology of the neuronal progenitors is involved in MDC onset.
The review is published in Frontiers in Neuroscience.
Share:
You could also like:
-
Italy at the centre of the Genome of Europe project
The Human Technopole, ELIXIR Italia, the national node of the European life sciences research infrastructure coordinated by the National Research Council (CNR), and the Centro Cardiologico Monzino, as the Italian coordinating centre, have been selected as the Italian partners of Genome of Europe (GoE), the largest EU-funded genomic project, whose ultimate goal is to make […]
-
Human Technopole wins 2024 Oscar di Bilancio
On Friday 13 December, at Palazzo Mezzanotte in Milan, the Human Technopole Foundation’s ‘Integrated Report 2023’ received the Oscar di Bilancio in the social enterprises and non-profit organisations category. The award was presented to President Gianmario Verona, Elena Trovesi, Head of Administration, as well as the project leaders Giovanni Selmi, Head of Finance, and Alessandro […]
-
Mosaic Organoids to Study the Brains of Multiple Patients Simultaneously
An international team of scientists from Human Technopole and the University of Milan has developed and validated an innovative approach to studying human brain development across multiple individuals simultaneously using single organoids—laboratory models that replicate key cellular processes of human neurodevelopment. The research paves the way for in vitro population studies. Additionally, the scientists have developed a novel computational method to more accurately quantify the genetic identity of individual cells profiled from multiple individuals concurrently. The findings have been published in Nature Methods.
-
Cancer stem cell morphology predicts glioblastoma growth and resistance
Human Technopole researchers have identified adducin-γ (ADD3) as a crucial regulator of glioblastoma cancer stem cell morphology and intercellular bridges between tumour cells. These connections facilitate communication and allow tumour cells to share resources, evade chemotherapy, and survive in challenging conditions. The study has been funded by AIRC and the findings are published in Life Science Alliance.
-
Colorectal Cancer: ML Enhances Cetuximab Response Predictions
An international collaborative study led by Human Technopole, Candiolo Cancer Institute IRCCS in Turin, the University of Turin, and the Wellcome Sanger Institute in Cambridge (UK) has identified new factors associated with therapeutic response in colorectal cancer. The research has led to the development of a machine-learning model capable of accurately predicting the effects of cetuximab, a drug in clinical use, on different colorectal tumour subtypes. Funded by the AIRC Foundation, the study paves the way to identifying molecular features that could serve as biomarkers for predicting treatment response in patients with this type of cancer.